Hogan & Hartson s Mok Discusses China s IP Challenges | GenomeWeb

Following last week's interview with General Biologic's Matthew Chervenak about the challenges of setting up a biotech business in China, we sought the opinion of an attorney about the legal issues Western companies face when they operate there. Attorney Arthur Mok works in the Shanghai office of intellectual property specialists Hogan & Hartson.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.